Trials / Conditions / Non-infectious Uveitis

Non-infectious Uveitis

23 registered clinical trials studyying Non-infectious Uveitis — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Proof-of-concept Trial to EvaluAte the efficaCy and Safety Of Cell Therapy TRX103 in Patients With Active, N NCT07427628	Quan Dong Nguyen	Phase 1
Recruiting	Suprachoroidal Triamcinolone in Macular Edema for Patients With Non-Infectious Uveitis Resistant to Subtenon T NCT07145008	University of Baghdad	EARLY_Phase 1
Completed	Mindfulness Approach for Reducing Anxiety and Gloom in Ocular Inflammatory Diseases NCT06585670	University of California, San Francisco	N/A
Active Not Recruiting	Incidence of Macular Edema in a Uveitis Population NCT06686641	Aalborg University Hospital	—
Not Yet Recruiting	Treatment FOr Corticosteroid Dependent UveitiS NCT06258915	Assistance Publique - Hôpitaux de Paris	Phase 3
Not Yet Recruiting	Prospective CoHoRt Of Non-infectious Intermediate, pOsterior or panuveitiS NCT05928754	Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts	N/A
Completed	Periodontal Status and Cytokine Levels in Patients With Non-Infectious Uveitis NCT07480291	Selcuk University	—
Completed	A 48 Week Study to Evaluate the Efficacy and Safety of Two (2) EYS606 Treatment Regimens in Subjects With Acti NCT04207983	Eyevensys	Phase 2
Completed	Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS NCT04018599	Fresenius Kabi SwissBioSim GmbH	Phase 1
Terminated	LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus NCT03711929	Santen Inc.	Phase 3
Completed	Evaluation of EYS606 in Patients With Non-infectious Posterior, Intermediate or Panuveitis NCT03308045	Eyevensys	Phase 1 / Phase 2
Terminated	Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye NCT02951975	Allergan	—
Completed	A Safety Study of Intravitreal PP-001 in Patients With Chronic, Non-Infectious Uveitis NCT03634475	Panoptes Pharma GmbH	Phase 1 / Phase 2
Completed	Utilization and Safety of the Mk II Inserter and the Safety of the FAI Insert in Non-Infectious Uveitis NCT02748512	EyePoint Pharmaceuticals, Inc.	Phase 3
Recruiting	Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis NCT02706704	American University of Beirut Medical Center	Phase 2
Completed	Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert NCT01694186	EyePoint Pharmaceuticals, Inc.	Phase 3
Terminated	Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis NCT01090310	Novartis Pharmaceuticals	Phase 3
Terminated	Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis NCT01032915	Novartis Pharmaceuticals	Phase 3
Unknown	Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease NCT00720928	Asan Medical Center	Phase 4
Completed	Safety and Efficacy of AIN457 in Noninfectious Uveitis NCT00685399	Novartis Pharmaceuticals	Phase 2
Terminated	The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis NCT00646425	Cerimon Pharmaceuticals	Phase 2
Terminated	Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant NCT00456482	Bausch & Lomb Incorporated	Phase 2 / Phase 3
Completed	Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy NCT00468871	Bausch & Lomb Incorporated	Phase 2 / Phase 3